Erythropoietin improves the postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model

Shock

Volumn 28, Issue 1, 2007, Pages 53-58

  Huang, Chien Hua ^a   Hsu, Chiung Yuan ^a   Chen, Huei Wen ^b   Tsai, Min Shan ^a   Cheng, Hsiao Ju ^a   Chang, Chia Hua ^a   Lee, Yuan Teh ^a   Chen, Wen Jone ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Cardioprotection; Cardiopulmonary resuscitation; Erythropoietin; Myocardial dysfunction; Postresuscitation

Indexed keywords

ADRENALIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLACEBO; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; ASPHYXIA; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; ENDOTRACHEAL TUBE; HEART ARREST; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; MALE; NONHUMAN; PROSPECTIVE STUDY; RAT; RESUSCITATION; SIGNAL TRANSDUCTION; VENTILATOR; WISTAR RAT;

ANIMALS; ASPHYXIA; CARDIOPULMONARY RESUSCITATION; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; HEART; HEART ARREST; MALE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34250740894     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31802f0218     Document Type: Article

References (35)

1. Becker LB, Ostrander MP, Barrett J, Kondos GT: Outcome of CPR in a large metropolitan area - where are the survivors? Ann Emerg Med 20:355-361, 1991.
2. Marenco JP, Wang PJ, Link MS, Homoud MK, Estes NAM III: Improving survival from sudden cardiac arrest: the role of the automated external defibrillator. JAMA 285:1193-1200, 2001.
3. White RD, Hankins DG, Atkinson EJ: Patient outcomes following defibrillation with a low energy biphasic truncated exponential waveform in out-of-hospital cardiac arrest. Resuscitation 49:9-14, 2001.
4. Ko PC, Ma MH, Yen ZS, Shih CL, Chen WJ, Lin FY: Impact of community-wide deployment of biphasic waveform automated external defibrillators on out-of-hospital cardiac arrest in Taipei. Resuscitation 63:167-174, 2004.
5. Schwarz B, Mair P, Raedler C, Deckert D, Wenzel V, Lindner KH: Vasopressin improves survival in a pig model of hypothermic cardiopulmonary resuscitation. Crit Care Med 30:1311-1314, 2002.
6. Weisfeldt ML, Becker LB: Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 288:3035-3038, 2002.
7. Becker LB: Minimizing hypoxic injury during cardiac arrest. New Horiz 5:145-152, 1997.
8. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, Cariou A, Rozenberg A, Carli P, Weber S, et al.: Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40:2110-2116, 2002.
9. Klouche K, Tang W, Weil MH: Research on postresuscitation myocardial dysfunction: potential limitations of isolated perfused heart models. Crit Care Med 28:3079-3080, 2000.
10. Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ: Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators. Shock 26:262-270, 2006.
11. Kern KB, Hilwig RW, Rhee KH, Berg RA: Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28:232-240, 1996.
12. Menasche P: Strategies to improve myocardial protection during extracorporeal circulation. Shock 16(suppl 1):20-23, 2001.
13. Bogoyevitch MA: An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 63:208-216, 2004.
14. Rui T, Feng Q, Lei M, Peng T, Zhang J, Xu M, Abel ED, Xenocostas A, Kvietys PR: Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res 65:719-727, 2005.
15. Cai Z, Semenza GL: Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109:2050-2053, 2004.
16. Smith KJ, Bleyer AJ, Little WC, Sane DC: The cardiovascular effects of erythropoietin. Cardiovasc Res 59:538-548, 2003.
17. Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, Doni M, Mengozzi M, Tonelli R, Ghezzi P, et al.: A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A 102:2046-2051, 2005.
18. Huang L, Weil MH, Tang W, Sun S, Wang J: Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med 33:487-491, 2005.
19. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M: Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100:4802-4806, 2003.
20. Abella BS, Zhao DH, Alvarado J, Hamann K, Vanden Hoek TL, Becker LB: Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation 109:2786-2791, 2004.
21. Huang L, Weil MH, Cammarata G, Sun S, Tang W: Nonselective betablocking agent improves the outcome of cardiopulmonary resuscitation in a rat model. Crit Care Med 32:378-380, 2004.
22. Cammarata G, Weil MH, Sun S, Tang W, Wang J, Huang L: Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival. Crit Care Med 32:440-443, 2004.
23. Kamohara T, Weil MH, Tang W, Sun S, Yamaguchi H, Klouche K, Bisera J: A comparison of myocardial function after primary cardiac and primary asphyxial cardiac arrest. Am J Respir Crit Care Med 164:1221-1224, 2001.
24. McCaul CL, McNamara P, Engelberts D, Slorach C, Hornberger LK, Kavanagh BP: The effect of global hypoxia on myocardial function after successful cardiopulmonary resuscitation in a laboratory model. Resuscitation 68:267-275, 2006.
25. Checchia PA, Sehra R, Moynihan J, Daher N, Tang W, Weil MH: Myocardial injury in children following resuscitation after cardiac arrest. Resuscitation 57:131-137, 2003.
26. Parish DC, nesh Chandra KM, Dane FC: Success changes the problem: why ventricular fibrillation is declining, why pulseless electrical activity is emerging, and what to do about it. Resuscitation 58:31-35, 2003.
27. Niemann JT, Stratton SJ, Cruz B, Lewis RJ: Outcome of out-of-hospital postcountershock asystole and pulseless electrical activity versus primary asystole and pulseless electrical activity. Crit Care Med 29:2366-2370, 2001.
28. Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI: Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci U S A 100:11612-11617, 2003.
29. Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, Kanamori H, Khai NC, Maruyama R, Ogino A, et al.: Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113:535-543, 2006.
30. Liu R, Suzuki A, Guo Z, Mizuno Y, Urabe T: Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem 96:1101-1110, 2006.
31. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A: Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22:10291-10301, 2002.
32. Zhang F, Signore AP, Zhou Z, Wang S, Cao G, Chen J: Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res 83:1241-1251, 2006.
33. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A: Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330-335, 2001.
34. Williams DL, Ozment-Skelton T, Li C: Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 25:432-439, 2006.
35. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM: Brainderived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19:2026-2028, 2005.